Arkolith/Insider Trading/IONS/Form 4

Bennett C Frank

EVP, Chief Scientific OfficerIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed Jul 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)6K$83.58$463K75K
Jul 7, 2026Other(J)15K—$015K
Jul 7, 2026Sell(S)15K$85.46$1.3M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Other(J)15K—$012K

Transaction Codes

S
Open-market sale
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000239) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML